Skip to content

The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01266382
Enrollment
Unknown
Registered
2010-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2010-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ligament Rupture, Lower Extremity Fracture, Neurological Disorders, Osteoarthritis, Spinal Diseases

Brief summary

The purpose of the study is to examine the effect of a new biomechanical device and treatment methodology (AposTherapy) on gait patterns, pain, function and quality of life of patients with musculoskeletal and neurological disorders. Based on previous reports the investigators hypothesis that this therapy will have a positive effect on these measurements.

Interventions

a biomechanical device including 2 hemispheric biomechanical elements attached to a platform in a form of a shoe. the biomechanical device is calibrated to each patient by a physiotherapist specialized with the treatment methodology. patient are instructed to walk indoor with the device. time of exercise is gradually increase

Sponsors

Apos Medical and Sports Technology Ltd.
CollaboratorINDUSTRY
Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Primary osteoarthritis * Lower limb joint replacement * Lower limbs fractures * Spinal disorders including LBP w/wo refered symptoms, radiculopathy, spinal stenosis * ligaments tear * Meniscal tears

Exclusion criteria

* lack of balance (3 falls in the last year) * incapable to complete a questionnaire •\>age 85

Design outcomes

Primary

MeasureTime frame
Spatio-temporal Gait parameters
WOMAC
SF-36

Secondary

MeasureTime frame
FAOS questionnaire
Oswestry questionnaire
Clinical measurements

Countries

Israel

Contacts

Primary ContactGanit Segal, MA
ganitm@apos.co.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026